Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,895,257 papers from all fields of science
Search
Sign In
Create Free Account
4-methylthiobenzoic acid
Known as:
4-MTBA
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Benzoate
Benzoates
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Optimization of silver nanoparticles for surface enhanced Raman spectroscopy of structurally diverse analytes using visible and near-infrared excitation.
Matthew W. Meyer
,
Emily A. Smith
In Analysis
2011
Corpus ID: 39194665
Several experimental parameters affecting surface enhanced Raman (SER) signals using 488, 785 and 1064 nm excitation for eight…
Expand
2005
2005
Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry.
A. H. Ewald
,
F. Peters
,
M. Weise
,
H. Maurer
Journal of chromatography. B, Analytical…
2005
Corpus ID: 138897
2004
2004
Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouse
H. Carmo
,
J. Hengstler
,
+7 authors
Maria Lourdes Bastos
Naunyn-Schmiedeberg's Archives of Pharmacology
2004
Corpus ID: 35836705
Several cases of death associated with 4-methylthioamphetamine (4-MTA) have raised public concern about the abuse of this…
Expand
Highly Cited
2000
Highly Cited
2000
Effect of protective agents against cisplatin ototoxicity.
L. Rybak
,
K. Husain
,
C. Morris
,
C. Whitworth
,
S. Somani
American Journal of Otology
2000
Corpus ID: 38266721
HYPOTHESIS The goals of this investigation were to compare the efficacy of three protective agents against cisplatin-induced…
Expand
Review
1999
Review
1999
Application of Antioxidants and Other Agents to Prevent Cisplatin Ototoxicity
L. Rybak
,
C. Whitworth
,
S. Somani
The Laryngoscope
1999
Corpus ID: 42542834
Objective/Hypothesis: To review the recent data from experiments performed in this laboratory to test the hypothesis that…
Expand
Highly Cited
1999
Highly Cited
1999
Effect of 4-methylthiobenzoic acid on cisplatin-induced ototoxicity in the rat 1 Part of this material was presented at the twenty-first Midwinter Research Meeting of the Association for Research…
T. Kamimura
,
C. Whitworth
,
L. Rybak
Hearing Research
1999
Corpus ID: 9918394
Highly Cited
1997
Highly Cited
1997
Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells.
R. Kopke
,
W. Liu
,
+9 authors
T. R. Van De Water
American Journal of Otology
1997
Corpus ID: 31425688
HYPOTHESIS Cisplatin causes the generation of reactive oxygen species (ROS), which interferes with the antioxidant defense system…
Expand
Highly Cited
1997
Highly Cited
1997
Protection by 4-methylthiobenzoic acid against cisplatin-induced ototoxicity: antioxidant system.
L. Rybak
,
K. Husain
,
L. Evenson
,
C. Morris
,
C. Whitworth
,
S. Somani
Acta Pharmacologica et Toxicologica
1997
Corpus ID: 36470997
This study was undertaken in order to determine the changes in auditory brainstem-evoked responses relationship with the changes…
Expand
1996
1996
4-methylthiobenzoic acid protection against cisplatin nephrotoxicity: antioxidant system.
K. Husain
,
C. Morris
,
C. Whitworth
,
G. Trammel
,
L. Rybak
,
S. Somani
Fundamental and Applied Toxicology
1996
Corpus ID: 11852970
This study investigates the changes in renal antioxidant system after cisplatin administration and the nephroprotection with 4…
Expand
1991
1991
4-Methylthiobenzoic acid reduces cisplatin nephrotoxicity in rats without compromising anti-tumour activity.
P. Boogaard
,
E. Lempers
,
G. Mulders
,
J. Meerman
Biochemical Pharmacology
1991
Corpus ID: 142398
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE